iShares Health Innovation Active ETF (BMED)
NYSEARCA: BMED · Real-Time Price · USD
30.74
-0.11 (-0.37%)
Feb 20, 2026, 4:00 PM EST - Market closed
BMED Holdings Information
BMED is an equity ETF with a total of 158 individual holdings. The top holdings are Johnson & Johnson stock at 4.84%, BLK CSH FND TREASURY SL AGENCY at 3.56%, Gilead Sciences at 3.36%, Edwards Lifesciences at 2.89%, and Roche Holding AG at 2.77%.
Total Holdings
158
Top 10 Percentage
29.64%
Asset Class
Equity
ETF Category
Health
Assets
9.88M
PE Ratio
25.82
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | 4.84% |
| 2 | XTSLA | BLK CSH FND TREASURY SL AGENCY | 3.56% |
| 3 | GILD | Gilead Sciences, Inc. | 3.36% |
| 4 | EW | Edwards Lifesciences Corporation | 2.89% |
| 5 | SWX: ROG | Roche Holding AG | 2.77% |
| 6 | AMGN | Amgen Inc. | 2.58% |
| 7 | MRK | Merck & Co., Inc. | 2.56% |
| 8 | BIIB | Biogen Inc. | 2.40% |
| 9 | GH | Guardant Health, Inc. | 2.35% |
| 10 | SWX: NOVN | Novartis AG | 2.32% |
| 11 | ISRG | Intuitive Surgical, Inc. | 2.21% |
| 12 | EXAS | Exact Sciences Corporation | 2.16% |
| 13 | DHR | Danaher Corporation | 2.07% |
| 14 | MRNA | Moderna, Inc. | 1.97% |
| 15 | COR | Cencora, Inc. | 1.84% |
| 16 | ARGX | argenx SE | 1.75% |
| 17 | DXCM | DexCom, Inc. | 1.63% |
| 18 | TEVA | Teva Pharmaceutical Industries Limited | 1.60% |
| 19 | RGEN | Repligen Corporation | 1.58% |
| 20 | MCK | McKesson Corporation | 1.57% |
| 21 | CRL | Charles River Laboratories International, Inc. | 1.56% |
| 22 | EBR: UCB | UCB SA | 1.43% |
| 23 | MDT | Medtronic plc | 1.43% |
| 24 | NTRA | Natera, Inc. | 1.39% |
| 25 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 1.39% |
As of Feb 20, 2026